Crinetics Pharmaceuticals, Inc. (NAS: CRNX) Stock Analysis & Fundamentals

CRNXCrinetics Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · crinetics.com

83.91USD+0.01%Mkt Cap: 8.88B $P/E: —1d ago

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The c…

Headline	Source	Time
This week
Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 10 affordable biotech stocks to buy right now. On July 6, Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) and Vertex Pharmaceuticals announced that both companies have agreed to a definitive agreement, according to which Vertex will acquire Crinetics Pharmaceuticals. The deal is priced at $85 a share in cash consideration, […]	Insider Monkey	1d
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals Vertex's $10 billion acquisition may have spooked investors, given how rich it appeared to be.	Motley Fool	Jul 14
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy? Vertex Pharmaceuticals recently announced its largest-ever acquisition.	Motley Fool	Jul 13
Older
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse	MarketBeat	Jul 11
Why This Pharmaceutical Stock Jumped Close to 100% This Week	Motley Fool	Jul 10
Why Crinetics Stock Soared 99% This Week	24/7 Wall St.	Jul 9
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT Newswires	Jul 8
Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?	Insider Monkey	Jul 8
Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal	Simply Wall St.	Jul 8
Vertex’s Crinetics Deal Balances Growth with Integration Risk	MarketBeat	Jul 8
Vertex Pharmaceuticals (VRTX) Buys Crinetics, Where Does Fair Value Sit Now?	Simply Wall St.	Jul 8
Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal	Simply Wall St.	Jul 8
Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.	Motley Fool	Jul 8
Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?	Zacks	Jul 8
VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?	Stocktwits	Jul 8
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today?	Stocktwits	Jul 8
Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know.	Motley Fool	Jul 8
Why Crinetics Stock Doubled After Vertex’s $10 Billion Buyout	BeInCrypto	Jul 8
Vertex (VRTX) Is Buying Crinetics For $10 Billion And Entering Endocrinology	Simply Wall St.	Jul 7
Sector Update: Healthcare Stocks Gain Late Afternoon	MT Newswires	Jul 7
Vertex Pays $10 Billion to Enter Rare Endocrine Disease	GuruFocus.com	Jul 7
This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal	Barrons.com	Jul 7
Top Midday Gainers	MT Newswires	Jul 7
CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition	Stocktwits	Jul 7
Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles	Investor's Business Daily	Jul 6
Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion	The Wall Street Journal	Jul 6
Crinetics soars on $10B acquisition by Vertex	Investing.com	Jul 6
Vertex to buy Crinetics for $10 billion to expand rare-disease business	Reuters	Jul 6
Sector Update: Healthcare Stocks Gain Late Afternoon	MT Newswires	Jul 2
Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock Positioned for Growth After Promising Atumelnant Clinical Results?	Insider Monkey	Jun 30
3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree	24/7 Wall St.	Jun 25
Leerink Upholds Outperform Rating for Crinetics Pharmaceuticals (CRNX)	Insider Monkey	Jun 17
Crinetics Pharmaceuticals (CRNX) is One of the Best AI Driven Biotech Stocks, Here is Why	Insider Monkey	Jun 11
A Look At Crinetics Pharmaceuticals (CRNX) Valuation As New Endocrine Data Heads To ENDO 2026	Simply Wall St.	Jun 4
What Do Analysts Say About Crinetics Pharmaceuticals (CRNX)?	Insider Monkey	May 29
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?	Motley Fool	May 18
Industry Analysts Just Upgraded Their Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Revenue Forecasts By 11%	Simply Wall St.	May 13
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates	Simply Wall St.	May 11
Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Momentum	Simply Wall St.	May 9
Crinetics (CRNX) Q1 2026 Earnings Transcript	Motley Fool	May 8
Crinetics Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary	Moby	May 8
Crinetics Pharmaceuticals Q1 Earnings Call Highlights	MarketBeat	May 8
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates	Zacks	May 7
The Bull Case For Crinetics Pharmaceuticals (CRNX) Could Change Following EU Nod For Oral Acromegaly Drug PALSONIFY	Simply Wall St.	May 4

Industry Peers